Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
AEON Biopharma, Inc. (AEON) had Normalized Pre-Tax Income of $-6.64M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.64M |
|
-- |
|
-- |
|
$4.34M |
|
$-4.34M |
|
$-2.30M |
|
$-6.64M |
|
|
Normalized Pre-Tax Income |
$-6.64M |
$-6.64M |
|
$-6.64M |
|
$-6.64M |
|
$-6.64M |
|
$-4.34M |
|
$-4.32M |
|
11.09M |
|
11.09M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$10.26M |
|
$0.20M |
|
$1.40M |
|
$11.66M |
|
$9.13M |
|
$15.17M |
|
$18.39M |
|
$27.51M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
11.54M |
|
| Cash Flow Statement Financials | |
$-10.00M |
|
$-0.00M |
|
$18.43M |
|
$0.01M |
|
$8.44M |
|
$8.43M |
|
$3.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
-22.38 |
|
-0.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
41.90% |
|
41.90% |
|
-56.95% |
|
979.65% |
|
$-1.37 |
|
$-0.90 |
|
$-0.90 |
|